Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




New Microarray Technology Enables Sequencing of Neanderthal DNA

By LabMedica International staff writers
Posted on 20 May 2010
By utilizing an advanced DNA capture technique, genomic researchers have succeeding in mapping a portion of the Neanderthal genome and comparing it to that of modern humans.

Investigators at the Max Planck Institute (Munich, Germany) , Cold Spring Harbor Laboratory (Cold Spring Harbor, NY, USA), and Agilent Technologies, Inc. More...
(Santa Clara, CA, USA) used Agilent's microarray system to sequence nearly 14,000 protein-coding positions inferred to have changed on the human lineage since the last common ancestor shared with chimpanzees.

Generally, it has been extremely difficult to work with ancient DNA due in part to chemical aging of the DNA molecules but even more so due to severe bacterial contamination of the samples. Now, in a study published in the May 7, 2010, issue of the journal Science, investigators from the three institutions described the use of array-hybridization capture technology, a process that enriched Neanderthal DNA sequences while depleting contaminant DNA. Thus, they were able to enrich Neanderthal protein-coding regions where differences occurred on the human evolutionary lineage up to 190,000-fold. By generating the sequence of one Neanderthal and 50 present-day humans, the investigators identified 88 amino acid substitutions that have become fixed in humans since our divergence from the Neanderthals.

"Attaining good coverage of the Neanderthal genome had been a problem due to DNA contamination from microbes over the years,” said senior investigator Dr. Svante Paabo, professor of evolutionary genetics at the Max Planck Institute. "Simply sequencing, without first enriching for the genome, often did not work, especially where the contamination levels were high. Array-hybridization capture technology was originally reported by the Cold Spring Harbor Laboratory group and is the subject of a longstanding collaboration with Agilent. The team recognized this as a promising method for recovering large regions of targeted sequence from Neanderthal samples. The method can also be used more widely with many other kinds of human remains.”

In a second article in the same issue of Science, the investigators presented their first detailed analysis of the draft sequence of the Neanderthal genome, which now includes more than three billion nucleotides collected from the bones of three female Neanderthals who lived in Croatia more than 38,000 years ago. By comparing this composite Neanderthal genome with the complete genomes of five living humans from different parts of the world, the investigators found that both Europeans and Asians share 1-4% of their nuclear DNA with Neanderthals, but that Africans do not. This suggests that early modern humans interbred with Neanderthals after moderns left Africa, but before they spread into Asia and Europe.

Related Links:

Max Planck Institute
Cold Spring Harbor Laboratory
Agilent Technologies



Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
ESR Analyzer
TEST1 2.0
HBV DNA Test
GENERIC HBV VIRAL LOAD VER 2.0
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.